BAYER AG (FRA: BAYN), the German pharmaceutical announced that between January and September achieved net profit of 3.497 million euros, up 9.2% yoy.
The company said in a statement that these results are due "primarily" by the "expansion" of sales of its HealthCare division of health equipment and all its departments, especially HealthCare and Covestro, which produces plastic components contributed to the breakthrough of gross.
Gross profit (EBITDA) of the accumulated in the first nine months company was EUR 7.718 million, 12.4% more than in the same period last year.
The company said in a statement that these results are due "primarily" by the "expansion" of sales of its HealthCare division of health equipment and all its departments, especially HealthCare and Covestro, which produces plastic components contributed to the breakthrough of gross.
Gross profit (EBITDA) of the accumulated in the first nine months company was EUR 7.718 million, 12.4% more than in the same period last year.